Nu-Med Plus, Inc. (NUMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 Q2 '12: 0 Q3 '12: 0 Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 0 Q3 '15: 0 Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q1 '25: 0 Q2 '25: 0 Q1 '26: 0 Q2 '26: 0 Q2 '13 Q3 '14 Q4 '15 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q1 '16: -65.7K Q2 '16: -178K Q3 '16: -695.8K Q4 '16: -285.1K Q1 '17: -69.7K Q2 '17: -111.3K Q3 '17: -137.7K Q4 '17: -147.7K Q1 '18: -142.6K Q2 '18: -168.7K Q3 '18: -522.1K Q4 '18: -336K Q1 '19: -423.7K Q2 '19: -243.8K Q3 '19: -146.2K Q4 '19: -205.7K Q1 '20: -149.3K Q2 '20: -904.4K Q3 '20: -449.8K Q4 '20: -491.2K Q1 '21: -356.7K Q2 '21: -252K Q3 '21: -118.4K Q4 '21: -112.3K Q1 '22: -59.7K Q2 '22: -58.1K Q3 '22: -58K Q4 '22: -6.4K Q1 '23: -27K Q2 '23: -23.1K Q3 '23: -15.1K Q4 '23: -55.3K Q1 '24: -20.6K Q2 '24: -16K Q3 '24: -17.4K Q4 '24: -9.3K Q1 '25: -18.7K Q2 '25: -10.4K Q1 '26: -13.2K Q2 '26: -22.6K Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q2 '26

Net Income Quarterly

-4M 0 4M 8M 12M Q1 '16: 11M Q2 '16: -228K Q3 '16: -772.2K Q4 '16: -319.6K Q1 '17: 4M Q2 '17: -116.1K Q3 '17: -143K Q4 '17: -152.6K Q1 '18: -147.5K Q2 '18: -173.6K Q3 '18: -526.8K Q4 '18: -341K Q1 '19: -428.2K Q2 '19: -248.2K Q3 '19: -150.6K Q4 '19: -209.9K Q1 '20: -153.3K Q2 '20: -908.5K Q3 '20: -453.8K Q4 '20: -493.4K Q1 '21: -356.7K Q2 '21: -242.6K Q3 '21: -118.4K Q4 '21: -112.3K Q1 '22: -56.7K Q2 '22: -58.1K Q3 '22: -58K Q4 '22: 42.6K Q1 '23: -28.2K Q2 '23: -24.3K Q3 '23: -16.4K Q4 '23: -56.6K Q1 '24: -21.8K Q2 '24: -17.3K Q3 '24: -18.7K Q4 '24: -10.6K Q1 '25: -19.9K Q2 '25: -11.7K Q1 '26: -15.9K Q2 '26: 19.7K Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-270K -180K -90K 0 90K 180K 270K Q3 '15: -39.3K Q4 '15: -47.5K Q1 '16: -50.3K Q2 '16: -49.8K Q3 '16: -38.9K Q4 '16: -41.2K Q1 '17: -73.9K Q2 '17: -89.6K Q3 '17: -127.8K Q4 '17: -139.2K Q1 '18: -81.8K Q2 '18: -99.6K Q3 '18: -142.9K Q4 '18: -143.3K Q1 '19: -246.7K Q2 '19: -120.5K Q3 '19: -75.5K Q4 '19: -124.7K Q1 '20: -95.2K Q2 '20: -147.3K Q3 '20: -101K Q4 '20: -71.3K Q1 '21: -79.2K Q2 '21: -66.4K Q3 '21: -41K Q4 '21: -20.2K Q1 '22: -12.1K Q2 '22: -2.5K Q3 '22: 628 Q4 '22: -24.4K Q1 '23: -20.2K Q2 '23: -23.1K Q3 '23: -18.9K Q4 '23: -4.3K Q1 '24: -450 Q4 '24: -1.7K Q1 '25: 0 Q2 '25: -1.5K Q1 '26: -6.4K Q2 '26: 1.1K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '26

Free Cash Flow Quarterly

-150K -100K -50K 0 50K 100K 150K Q1 '12: -29.5K Q2 '12: -37.3K Q3 '12: -26.8K Q4 '12: -29.4K Q1 '13: -36.1K Q2 '13: -33K Q3 '13: -39.9K Q4 '13: -60.4K Q1 '14: -43.9K Q2 '14: -42.4K Q3 '14: -35.3K Q4 '14: -37.8K Q3 '17: -127.8K Q4 '17: -139.2K Q3 '18: -142.9K Q4 '18: -143.3K Q4 '19: -124.7K Q2 '12 Q1 '13 Q4 '13 Q3 '14 Q4 '17 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q2 '12: 24.1M Q3 '12: 26.7M Q1 '13: 26.8M Q2 '13: 26.8M Q3 '13: 27.6M Q1 '14: 31.7M Q2 '14: 32.3M Q3 '14: 32.8M Q1 '15: 34.3M Q2 '15: 34.3M Q3 '15: 35.8M Q1 '16: 65.4M Q2 '16: 36.5M Q3 '16: 38M Q1 '17: 75.3M Q2 '17: 34.2M Q3 '17: 37.3M Q1 '18: 37.6M Q2 '18: 37.8M Q3 '18: 39M Q1 '19: 41.5M Q2 '19: 45.3M Q3 '19: 46M Q1 '20: 46.6M Q2 '20: 47.3M Q3 '20: 50.3M Q1 '21: 79.3M Q2 '21: 79.3M Q1 '22: 79.3M Q2 '22: 79.3M Q3 '22: 79.7M Q1 '23: 81.3M Q2 '23: 81.3M Q3 '23: 81.3M Q1 '24: 83.5M Q3 '24: 81.3M Q1 '25: 83.5M Q2 '25: 83.5M Q1 '26: 83.5M Q2 '26: 83.5M Q3 '13 Q2 '15 Q1 '17 Q3 '18 Q2 '20 Q2 '22 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.05 0.00 0.05 0.10 0.15 Q3 '15: -0.04 Q4 '15: -0.03 Q1 '16: 0.14 Q2 '16: 0.14 Q3 '16: 0.13 Q4 '16: 0.13 Q1 '17: 0.01 Q2 '17: 0.02 Q3 '17: 0.04 Q4 '17: 0.05 Q1 '18: 0.00 Q2 '18: 0.00 Q3 '18: -0.01 Q4 '18: -0.02 Q1 '19: -0.03 Q2 '19: -0.03 Q3 '19: -0.02 Q4 '19: -0.01 Q1 '20: 0.00 Q2 '20: -0.02 Q3 '20: -0.03 Q4 '20: -0.04 Q1 '21: -0.04 Q2 '21: -0.02 Q3 '21: -0.01 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.